How the COVID-19 pandemic has influenced pediatric rheumatology practice: Results of a global, cross-sectional, online survey

被引:24
作者
Batu, Ezgi Deniz [1 ]
Lamot, Lovro [2 ,3 ]
Sag, Erdal [1 ]
Ozen, Seza [1 ]
Uziel, Yosef [4 ,5 ]
机构
[1] Hacettepe Univ, Fac Med, Dept Pediat, Div Rheumatol, Ankara, Turkey
[2] Sestre Milosrdnice Univ Hosp Ctr, Dept Pediat, Div Clin Immunol & Rheumatol, Zagreb, Croatia
[3] Univ Zagreb, Sch Med, Dept Pediat, Zagreb, Croatia
[4] Meir Med Ctr, Pediat Rheumatol Unit, Kefar Sava, Israel
[5] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel
关键词
COVID-19; Pandemic; Pediatric rheumatology; Survey; Kawasaki disease; Macrophage activation syndrome; RISK; HYDROXYCHLOROQUINE; MANAGEMENT; INFECTION; ARTHRITIS; SERIES;
D O I
10.1016/j.semarthrit.2020.09.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The COVID-19 pandemic is a global health problem. We, as the EMERGE (EMErging RheumatoloGists and rEsearchers) group of PReS (Pediatric Rheumatology European Society) analyzed how the pandemic has affected pediatric rheumatology practice. Methods: An online survey was developed to assess changes in pediatric rheumatology practice due to the pandemic. Results were analyzed using descriptive statistics. Results: From 70 countries, 493 pediatric rheumatologists (80.3% in pediatric rheumatology practice for >= 5 years) responded to the survey. Around 70% disagreed that the pandemic led to reduced prescription of nonsteroidal anti-inflammatory drugs, conventional synthetic and biologic disease-modifying antirheumatic drugs. Almost half were more likely to taper corticosteroids faster. One-fifth hesitated to switch the major immunosuppressant during a flare. Patients encountering difficulties obtaining hydroxychloroquine and tocilizumab due to shortages were noted by 192 (38.9%) and 44 (8.9%), respectively. Twenty to 30% indicated that their patients had experienced a flare or delay in diagnosis/intervention due to postponed appointments.53% mentioned use of phone calls/smartphone applications while 47% shifted towards video consultations for patient care. Respondents indicated an increased number of patients with Kawasaki disease (30%), macrophage activation syndrome (15.6%), unusual vasculitic rashes (31.4%), and hyperinflammation (33.5%) during the pandemic. Conclusion: This is the largest survey to date addressing changes in pediatric rheumatology practice due to the COVID-19 pandemic. Primary changes were due to delays in clinic appointments, increase in use of virtual technologies, and concerns about the use of immunosuppressive therapies. An increased number of patients with Kawasaki disease/hyperinflammation mentioned by the respondents is noteworthy. (C) 2020 Elsevier Inc. All rights reserved.
引用
收藏
页码:1262 / 1268
页数:7
相关论文
共 44 条
[41]   COVID-19 and smoking: A systematic review of the evidence [J].
Vardavas, Constantine I. ;
Nikitara, Katerina .
TOBACCO INDUCED DISEASES, 2020, 18
[42]   Telehealth transformation: COVID-19 and the rise of virtual care [J].
Wosik, Jedrek ;
Fudim, Marat ;
Cameron, Blake ;
Gellad, Ziad F. ;
Cho, Alex ;
Phinney, Donna ;
Curtis, Simon ;
Roman, Matthew ;
Poon, Eric G. ;
Ferranti, Jeffrey ;
Katz, Jason N. ;
Tcheng, James .
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2020, 27 (06) :957-962
[43]   The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China [J].
Zhang, Wen ;
Zhao, Yan ;
Zhang, Fengchun ;
Wang, Qian ;
Li, Taisheng ;
Liu, Zhengyin ;
Wang, Jinglan ;
Qin, Yan ;
Zhang, Xuan ;
Yan, Xiaowei ;
Zeng, Xiaofeng ;
Zhang, Shuyang .
CLINICAL IMMUNOLOGY, 2020, 214
[44]   Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study [J].
Zhou, Fei ;
Yu, Ting ;
Du, Ronghui ;
Fan, Guohui ;
Liu, Ying ;
Liu, Zhibo ;
Xiang, Jie ;
Wang, Yeming ;
Song, Bin ;
Gu, Xiaoying ;
Guan, Lulu ;
Wei, Yuan ;
Li, Hui ;
Wu, Xudong ;
Xu, Jiuyang ;
Tu, Shengjin ;
Zhang, Yi ;
Chen, Hua ;
Cao, Bin .
LANCET, 2020, 395 (10229) :1054-1062